Patents by Inventor Chih-Wei FU

Chih-Wei FU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND, PHARMACEUTICAL COMPOSITION, KIT FOR CAPPED RNA TRANSCRIPT, AND METHOD FOR IN VITRO
    Publication number: 20250230184
    Abstract: A compound, pharmaceutical composition, kit for capped RNA transcript, and method for in vitro transcription are provided. The compound has a structure represented by Formula (I), Formula (II), or Formula (III) wherein A1, A2, R1, R2, R9, R10, Q1, Q2, Q3, Q4, Q5, Q6, Y1, Y2, Y3, and Z are as disclosed in the specification.
    Type: Application
    Filed: December 23, 2024
    Publication date: July 17, 2025
    Applicant: Industrial Technology Research Institute
    Inventors: Chih-Wei FU, Hao-Hsuan LIU, Ching-Wen YANG, Ming-Hsi WU, Hsiu-Chuan LI, Ssu-Yuan WU
  • Androgen receptor binding molecule and use thereof
    Patent number: 12152035
    Abstract: An androgen receptor (AR) binding molecule has the structure of Formula (I) shown in the following: wherein E is CH2, G is CH, is OH, NH2, OTf or C?C, X is CF3 or trifluoromethylphenyl, is a single bond, and Y and Z are CH2; or is absent, X is CF3, is a double bond, and Y and Z are CH.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: November 26, 2024
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Chih-Wei Fu, Hao-Hsuan Liu, Chiu-Lien Hung, Yu-Chin Lin, Tsan-Lin Hu, Chien-Chin Huang
  • LIPID COMPOUND OR A DERIVATIVE THEREOF AND PHARMACEUTICAL COMPOSITION EMPLOYING THE SAME
    Publication number: 20240189243
    Abstract: A lipid compound or a derivative thereof and a pharmaceutical composition employing the same are provided. The lipid compound has a structure represented by Formula (I): wherein Z1, Z2, Z3 and Z4 are as disclosed in the specification.
    Type: Application
    Filed: November 13, 2023
    Publication date: June 13, 2024
    Applicant: Industrial Technology Research Institute
    Inventors: Felice Cheng, Ping-Fu Cheng, Jenn-Tsang Hwang, Chih-Wei Fu, Ku-Feng Lin, Ya-Ling Chiu, Jheng-Sian Li, Kang-Li Wang, Siou-Han Chang, Chia-Yu Fan
  • NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS
    Publication number: 20230234912
    Abstract: A series of novel analogs of water soluble pterostilbene amino acid bearing carbonates were synthesized, which show activities in treating a non-alcoholic fatty liver disease and a nonalcoholic steatohepatitis (NASH).
    Type: Application
    Filed: June 8, 2021
    Publication date: July 27, 2023
    Inventors: TAI-HUANG KUO, PO-CHUEN SHIEH, MING-LONG CHENG, CHIH-WEI FU
  • Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and method for performing an in vivo related application that benefits from the inhibition of a kinase
    Patent number: 11608319
    Abstract: A compound represented by Formula (I), a pharmaceutically acceptable salt or ester, hydrate, solvate or crystalline form thereof is provided: The compound represented by Formula (I) is a ?-amino acid derivative, and in Formula (I) X is a single bond or O; Y is NH or C?O; Z is C?O, C?S, NH, W is C or N; A is a single bond, O, OH, OCH2, a heterocycle or N3; R1 is H or F; R2 is H, F, OH, CF3, CH2OH, CHO or R3 is H; n is 0 or 1; and m is 0 or 1.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: March 21, 2023
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Chih-Wei Fu, Chih-Peng Liu, Yi-Hsun Chen, Chia-Mu Tu, Chiu-Lien Hung
  • BETA-AMINO ACID DERIVATIVE, KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND METHOD FOR PERFORMING AN IN VIVO RELATED APPLICATION THAT BENEFITS FROM THE INHIBITION OF A KINASE
    Publication number: 20220363645
    Abstract: A compound represented by Formula (I), a pharmaceutically acceptable salt or ester, hydrate, solvate or crystalline form thereof is provided: The compound represented by Formula (I) is a ?-amino acid derivative, and in Formula (I) X is a single bond or O; Y is NH or C?O; Z is C?O, C?S, NH, W is C or N; A is a single bond, O, OH, OCH2, a heterocycle or N3; R1 is H or F; R2 is H, F, OH, CF3, CH2OH, CHO or R3 is H; n is 0 or 1; and m is 0 or 1.
    Type: Application
    Filed: December 10, 2020
    Publication date: November 17, 2022
    Applicant: Industrial Technology Research Institute
    Inventors: Chih-Wei FU, Chih-Peng LIU, Yi-Hsun CHEN, Chia-Mu TU, Chiu-Lien HUNG
  • ANDROGEN RECEPTOR BINDING MOLECULE AND USE THEREOF
    Publication number: 20220227771
    Abstract: An androgen receptor (AR) binding molecule has the structure of Formula (I) shown in the following: wherein E and G independently are CH2 or CH, is OH, NH2, OTf or C?C, X is CF3 or trifluorophenyl, and Y and Z independently are CH2 or CH; or is absent, X is CF3, and Y and Z independently are CH2.
    Type: Application
    Filed: December 23, 2021
    Publication date: July 21, 2022
    Applicant: Industrial Technology Research Institute
    Inventors: Chih-Wei FU, Hao-Hsuan LIU, Chiu-Lien HUNG, Yu-Chin LIN, Tsan-Lin HU, Chien-Chin HUANG